The Acute Care Hospital at Home model (ACHAH) provides traditional hospital inpatient acute-level services at home. Prior to the pandemic a Centers for Medicare and Medicaid pilot study yielded positive results with respect to hospital readmission rates and follow-up emergency department visits. The ACHAH model appears to be a feasible alternative to traditional inpatient acute care that can improve quality of care and patient satisfaction. What was previously a trickle of interest turned into a wave of necessity as the pandemic overwhelmed hospitals and the health care system in 2020. In response to the pandemic, CMS began to provide hospital with broad regulatory flexibility to implement the ACHAH model.
Dominic Castillo
As a healthcare attorney, Dominic helps providers navigate a highly regulated landscape so they can focus on optimal patient care. Dominic guides a wide range of clients – from individual practitioners to large national hospital systems – on ever-changing state and federal regulations. Skilled nursing facilities, assisted living facilities, hospices and home health agencies are among those relying on Dominic’s guidance regarding compliance, transactional and licensure matters including:
- Health Insurance Portability and Accountability Act (HIPAA)
- Medicare and Medicaid reimbursement
- Stark Law compliance
- Anti-Kickback Statute (AKS)
- False Claims Act (FCA)
Healthcare Providers to Receive $25.5 Billion in Relief Funds
On September 10, the Biden-Harris Administration, in conjunction with the Department of Health and Human Services (HHS), announced that $25.5 billion in relief funds will be distributed to healthcare providers through the Health Resources and Services Administration (HRSA). The American Rescue Plan (ARP) will provide $8.5 billion in funding and an additional $17 billion will be distributed as Phase 4 Provider Relief Funds (PRF).
Wisconsin Business Entities Granted Civil Immunity for COVID-19 Exposure
On February 25, 2021, the Wisconsin Legislature enacted 2021 Wisconsin Act 4 (the “Act”), which, in part, grants immunity to business entities from civil liability related to COVID-19 exposure, with certain exceptions.
Specifically, the Act immunizes certain entities from civil liability for any act or omission in the course of performance or provision of the entity’s function or services, that leads to death or injury to an individual or damages caused by an act or omission resulting from or relating to exposure directly or indirectly to COVID-19 (or its variants), or conditions associated with the infectious disease. However, civil immunity does not extend to acts or omissions that are reckless, wanton conduct, or intentional misconduct.